Compare ACET & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACET | AXIL |
|---|---|---|
| Founded | 1947 | 2015 |
| Country | United States | United States |
| Employees | 102 | 15 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 36.6M |
| IPO Year | 2017 | 2017 |
| Metric | ACET | AXIL |
|---|---|---|
| Price | $3.41 | $5.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $34.83 | N/A |
| AVG Volume (30 Days) | ★ 187.5K | 21.4K |
| Earning Date | 11-13-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 230.00 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $30,847,570.00 |
| Revenue This Year | N/A | $12.27 |
| Revenue Next Year | N/A | $20.93 |
| P/E Ratio | ★ N/A | $107.40 |
| Revenue Growth | N/A | ★ 17.48 |
| 52 Week Low | $0.46 | $4.28 |
| 52 Week High | $9.97 | $9.86 |
| Indicator | ACET | AXIL |
|---|---|---|
| Relative Strength Index (RSI) | 18.83 | 47.95 |
| Support Level | N/A | $5.35 |
| Resistance Level | $9.59 | $6.47 |
| Average True Range (ATR) | 0.34 | 0.44 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 3.39 | 50.00 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
AXIL Brands Inc is engaged in the manufacturing, marketing, sale, and distribution of high tech hearing and audio enhancement and protection products, professional quality hair and skin care products, and the delivery of marketing services. The company has three operating segments: hearing enhancement and protection, hair and skin care and marketing services. The company generates majority of revenue from Hearing enhancement and protection segment. Hearing Enhancement and Protection Products are In-ear protection devices, Over-ear protection devices, and Accessories and others.